Kala Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
May 27 2020 - 8:00AM
Business Wire
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical
company focused on the discovery, development and commercialization
of innovative therapies for diseases of the eye, today announced
that it will present at the Jefferies Virtual Healthcare
Conference. Mark Iwicki, Chairman, President and Chief Executive
Officer of Kala Pharmaceuticals, is scheduled to participate in a
fireside chat on Wednesday, June 3rd, 2020 at 8:30 a.m. ET.
To access a live webcast and subsequent archived recording of
the presentation, please visit the “Investors & Media” section
on the Kala website at http://kalarx.com
About Kala Pharmaceuticals, Inc.
Kala is a biopharmaceutical company focused on the discovery,
development and commercialization of innovative therapies for
diseases of the eye. Kala has applied its AMPPLIFYTM mucus
penetrating particle Drug Delivery Technology to a corticosteroid,
loteprednol etabonate (LE), designed for ocular applications,
resulting in the January 2019 launch of INVELTYS® (loteprednol
etabonate ophthalmic suspension) 1% and its investigational product
candidate, EYSUVISTM (loteprednol etabonate ophthalmic suspension)
0.25%, for which Kala recently resubmitted its New Drug Application
to the FDA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200527005003/en/
Investor Contact: Hannah Deresiewicz
hannah.deresiewicz@sternir.com 212-362-1200
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Jun 2024 to Jul 2024
KALA BIO (NASDAQ:KALA)
Historical Stock Chart
From Jul 2023 to Jul 2024